文献速递心血管胸部PETMR

FDG PET联合心脏MRI用于心脏结节病的诊断与治疗监测评估

Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
PubMed 文献 · Clin Radiol · 2018-10-25

回顾性纳入80例疑似心脏结节病的结节病患者,比较FDG PET与CMR的诊断一致性及治疗监测价值。治疗中PET表现全部改善(7/7),而LGE仅33%改善(3/9)。

要点

  • 治疗中PET表现全部改善(7/7),LGE仅33%(3/9)改善。

核心结论

  • 由于假阳性或不确定结果风险高,PET可作为LGE病例的二线检查以评估炎症负荷;PET似乎适合预测和评估治疗反应。

研究设计与样本

  • 回顾性纳入80例疑似心脏结节病的结节病患者,均行FDG PET和CMR;PET采用低糖高脂饮食后16排PET/CT相机采集;50例(50/80)在治疗中监测并分为应答者与非应答者。

关键影像表现/征象

  • PET阳性定义为局灶或多灶性FDG摄取。
  • CMR阳性定义为心外膜下延迟钆增强(LGE)。

诊断标准与关键数值

  • PET阳性标准为局灶或多灶性FDG摄取。
  • CMR阳性标准为心外膜下LGE。

临床应用与阅片要点

  • 基线PET阳性者临床应答较基线PET阴性者更常见(80% vs 45%,p=0.07)。
  • 治疗中PET表现全部改善(7/7),而LGE仅33%(3/9)改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To compare combined 2-[18F]-fluoro-2-deoxy-d-glucose (FDG)-positron-emission tomography (PET) and cardiac magnetic resonance imaging (CMR) for the diagnosis and therapy monitoring of cardiac sarcoidosis (CS).

MATERIALS AND METHODS: Eighty patients with sarcoidosis and a suspicion of CS who underwent PET and CMR were included retrospectively. PET was undertaken after a low-carbohydrate-high-fat diet in all patients using a combined 16-section PET/computed tomography (CT) camera. PET was considered positive (PET+) in cases of focal or multifocal FDG uptake. CMR was considered positive (CMR+) in cases of subepicardial late gadolinium enhancement (LGE). A subgroup of 50 patients (50/80) was monitored during therapy and classified as responders or non-responders.

RESULTS: Eighty-two percent of patients with PET+ (9/11) also had CMR+ imaging, with good spatial agreement (kappa=0,79; 95% confidence interval [CI]: 0.65-0.94). Twenty-seven percent (22/80) had residual physiological FDG uptake, with a standardised uptake value (SUV) not significantly different compared to the SUV from pathological uptake (6.4 versus 6 respectively, p=0,92). The clinical response was more frequent in patients with baseline PET+ compared to baseline PET- (80% versus 45%, p=0.07). PET findings improved in all cases under treatment (7/7), whereas LGE improved in only 33% of patients (3/9).

CONCLUSION: Due to high risk of false-positive or undetermined findings, PET might be performed as a second-line study in cases of LGE, to assess inflammatory load. In addition, PET seems suitable to predict and assess response under therapy.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Sgard B, Brillet PY, Bouvry D, et al. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis. Clin Radiol. 2018. PMID: 30482560. doi:10.1016/j.crad.2018.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。